Colorectal Cancer. Disease and Advanced Drug Delivery Strategies

Table of Contents

1. Colorectal Cancer: Understanding of disease
2. Impact of the microbiome on colorectal cancer development
3. Advanced Microfluidic Systems for the colorectal cancer diagnosis and its clinical application
4. Transarterial radioembolization and its impacts on colon cancer treatment and diagnosis
5. Current drug therapy in Colorectal Cancer
6. Recent advancements in Immunotherapy in colon cancer targeting
7. Novel targeting formulations in Colorectal Cancer
8. Polymeric nanoparticles in Colorectal Cancer
9. Lipid nanoparticles in Colorectal Cancer
10. Micro, nano emulsions in Colorectal Cancer
11. A unique compilation of Whole-Systems approaches to curtail colon cancer through Herbal Medicine
12. Bacteriotherapy in Colorectal cancer
13. Biomarker and theranostic in colorectal cancer
14. Advance precision medicine to combat colorectal cancer
15. Recent updates of clinical trials for Colorectal Cancer
16. Disease Models in Colorectal Cancer Research
17. An Outlook into Liposomal Drug Delivery of Chemotherapeutic Agents to Combat Colorectal Cancer
18. Novel targeting strategies on signaling pathway-Responsible for colorectal cancer
19. Decipher the role of Cancer Stem Cells in Colorectal Cancer based on molecular pathology and its clinical significance

Authors

Bhupendra Prajapati Professor, Dept. of Pharmaceutics and Pharmaceutical Technology, Shree S.K. Patel College of Pharmaceutical Education & Research, Faculty of Pharmacy, Ganpat University. Dr. Prajapati is a Professor in Department of Pharmaceutics, Shree S.K.Patel College of Pharmaceutical Education and Research, Ganpat University, Gujarat, India. He has more than 20 years of academic and research experience, has published more than 100 research and review papers in international and national Journals. Under his editorial two book under process and he authored 20 book chapters in the field of novel drug delivery. He published two Indian patent and three application under evaluation. He is a reviewer in three high impact journals and is on the editorial board of several scientific journals. Anil K. Philip Associate Dean (Head), School of Pharmacy, University of Nizwa, Oman. Dr. Anil Philip is currently working as Associate Dean (Head), School of Pharmacy, University of Nizwa, Oman. Among other credentials, he served as a member of the Health and Social Sciences sectorial grant committee of The Research Council, Oman, and as Faculty Mentored Undergraduate Research Program general supervisor to promote undergraduate research at the University of Nizwa. His research objectives and achievements have been in controlling/modifying the release of small/large molecules targeted to GI space using phase-transited delivery systems. He has worked extensively in the field of controlled/ modified drug release systems. Currently, his research focuses on developing nano-drug delivery systems, which can be targeted to the various body organs. He has guided students in areas of targeted drug delivery, has more than 40 original research publications in international peer-reviewed journals, and two patents on drug delivery systems. Sankha Bhattacharya Associate Professor, Department of Pharmaceutics, School of Pharmacy and Technology Management, SVKM'S NMIMS Deemed-to-be University, Shirpur, Maharashtra, India. Dr. Sankha Bhattacharya did his Post Doctorate from the Indian Institute of Technology (BHU), Varanasi, INDIA (August 2018-August 2019) in cancer nanomedicine and molecular pharmaceutics. He is currently serving as an Associate Professor in the Department of Pharmaceutics, School of Pharmacy & Technology Management Shirpur, SVKM'S NMIMS Deemed-to-be University, India with 9.3 years of Research and Teaching experiences. He has published more than 32 national and 18 international papers in high impact factor and peer-reviewed journals. He also published five book chapters on the global platform.